2802.T
Stock Details
2802.T is Ajinomoto Co., Inc.'s stock. Stock exchange Tokyo (Currency JPY). Average price in 50 days is 4,236.98๏ฟฅ. Average daily volumn in 3 months 1.97M. Market cap 2.29T
Stock symbol : 2802.T. Exchange : Tokyo. Currency : JPY Lastest price : 4,273.00๏ฟฅ. Total volume : 1.84M. Market state POSTPOST Click reload if you want to check the lastest price on market!!!
Ajinomoto Co., Inc. (2802.T)
Last Price
4,273.00๏ฟฅChange
49.00Volume
1.84M
Previous Close | 4,224.00 |
Open | 4,223.00 |
Day Range | 4,221.00-4,277.00 |
Bid | 4,266.00 x N/A |
Ask | 4,274.00 x N/A |
Volume | 1.84M |
Average Volume | 1.97M |
Market Cap | 2.29T |
Beta | -0.02 |
52 Week Range | 2,879.00-4,573.00 |
Trailing P/E | 33.34 |
Foward P/E | 24.19 |
Dividend (Yield %) | 1.47% |
Ex-Dividend Date | 2023-03-30 |
Financial Details

Organization
Ajinomoto Co., Inc. engages in the seasonings and foods, frozen foods, and healthcare and other businesses in Japan and internationally. The company operates through three segments: Seasonings and Foods; Frozen Foods; and Healthcare and Others. The Seasonings and Foods segment offers sauces and seasonings products under the AJI-NO-MOTO, HON-DASHI, Cook Do, Ajinomoto KK Consommรฉ, Pure Select Mayonnaise, Ros Dee, Masako, Aji-ngon, Sazรณn, Sajiku, and CRISPY FRY names; and solutions and ingredient... s to consumer foods and food service industries. This segment also provides instant noodles under the Knorr Cup Soup and YumYum names; coffee under the Birdy and Blendy brands; powdered drink under the Birdy 3in1 name; MAXIM products; Chyotto Zeitakuna Kohiten products; and gift sets and office supplies comprising coffee vending machines, tea servers, etc. The Frozen Foods segment offers Chinese dumplings, cooked rice, noodles, desserts, shumai, processed chicken, and other products. The Healthcare and Other segment provides amino acids to various industries, such as pharmaceuticals and foods; sports nutrition products; and personal care ingredients, as well as engages in the provision of contract manufacturing services for pharmaceutical intermediates and active ingredients, and sterile products. This segment also offers Ajinomoto Build-up Film, an interlayer insulating material for semiconductor packages; food and drink products under the Glyna, Amino Aile, and amino VITAL names; and functional materials. The company was founded in 1909 and is headquartered in Tokyo, Japan.
Market Cap:
2.29TRevenue:
1.15TTotal Assets:
1.46TTotal Cash:
151.45B
News about "Ajinomoto Co., Inc."
Ajinomoto Co., Inc.
Source from : Nikkei Asia - 11 days ago
Ajinomoto Co., Inc. engages in the manufacture, distribution, and sale of food products, amino acids, and pharmaceuticals. It operates through the following segments: Seasoning and Foods ...See details»
Fermentation Chemicals Market Size 2023 with Economical Benchmarking, Old Statistics and Forecasts, Company Returns Shares
Source from : MarketWatch - 1 days ago
Fermentation Chemicals market has witnessed a growth from USD million to USD million from 2017 to 2022. With a CAGR ...See details»
Ajinomoto and Exelixis Enter Into a License Agreement to Discover and Develop Novel Antibody-Drug Conjugates for the Treatment of Cancer
Source from : Yahoo Finance - 21 days ago
TOKYO, Jan. 10, 2023 /PRNewswire/ -- Ajinomoto Co., Inc. ("Ajinomoto Co.") today announced a license agreement with Exelixis, Inc. ("Exelixis") to incorporate AJICAP ...See details»
Ajinomoto earnings preview: what Wall Street is expecting
Source from : Business Insider - 1 year ago
Ajinomoto will release figures for the most recent quarter on January 31.Wall Street predict expect Ajinomoto will report earnings per share of ...See details»
What Wall Street expects from Ajinomoto's earnings
Source from : Business Insider - 2 month ago
Ajinomoto will be reporting earnings from the last quarter on January 31.Wall Street analysts are expecting earnings per share of ยฅ51.92.Track ...See details»
Ajinomoto supports coffee farmersโ sustainable productivity
Source from : Bangkok Post - 12 days ago
Ajinomoto aims to conduct its business toward sustainable development. In addition to setting a goal to reduce the environmental impacts of its business activities, the company has initiated ...See details»
Ajinomoto Bio-Pharma Services
Source from : FiercePharma - 8 month ago
Ajinomoto Bio-Pharma Services is a fully integrated and comprehensive CDMO for small and large molecule APIs, including ADCs, oligonucleotides and aseptic fill finish.See details»
Mayonnaise Market Huge Growth in Future Scope 2023-2030 and Market Sales Growth Analysis | Nestlรฉ SA, Ajinomoto Co., Inc., McCormick & Company
Source from : Digital Journal - 21 days ago
Leading company profiles are based on a range of factors such as markets served, production, revenue, market share, recent innovations, and gross profit margins. A specialized market dynamics ...See details»
Ajinomoto (Malaysia) Bhd 2658 (Malaysia)
Source from : Wall Street Journal - 11 days ago
Noriko Fujimoto Executive Director Fujimoto Foods, Inc., Ajinomoto (Malaysia ... Chiang Liang Teo Chairman Ajinomoto (Malaysia) Bhd., Malaysia Ve-Tsin Manufacturing Co. Bhd.See details»
Ajinomoto promotes healthy living, reduces salt consumption
Source from : Vanguard - 22 days ago
Food experts and management of Ajinomoto Foods Nigeria Limited have said the use of AJinomoto food season promotes healthy living by enhancing the flavour of food and reducing excessive salt ...See details»
Ajinomoto PH opens 2024 graduate scholarship in Japan
Source from : The Manila Times on MSN - 20 days ago
AJINOMOTO Philippines Corp. (APC) is accepting applications to its scholarship program aimed to support deserving Filipinos who require financial assistance to pursue postgraduate studies in the field ...See details»
Ajinomoto Co., Inc.
Source from : Nikkei Asia - 25 days ago
Ajinomoto Co., Inc. engages in the manufacture, distribution, and sale of food products, amino acids, and pharmaceuticals. It operates through the following segments: Seasoning and Foods ...See details»
Ajinomoto Co Inc ADR (AJINY)
Source from : Investing - 6 days ago
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...See details»
Ajinomoto and Exelixis Enter Into a License Agreement to Discover and Develop Novel Antibody-Drug Conjugates for the Treatment of Cancer
Source from : PR Newswire - 21 days ago
TOKYO, Jan. 10, 2023 /PRNewswire/ -- Ajinomoto Co., Inc. ("Ajinomoto Co.") today announced a license agreement with Exelixis, Inc. ("Exelixis") to incorporate AJICAP ...See details»